Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:32 PM
Ignite Modification Date: 2025-12-25 @ 5:14 PM
NCT ID: NCT03377803
Description: Only TEAEs were to be considered.
Frequency Threshold: 5
Time Frame: Baseline Visit to EOS Visit 84 Days (12 weeks)
Study: NCT03377803
Study Brief: Cantharidin Application in Molluscum Patients
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
VP-102 VP-102 Film Forming Solution applied via a prefilled applicator to affected area every 21 days VP-102: VP-102 Active will be administered via the applicator to Molluscum lesions Applicator: Used to apply the topical film forming Active or Placebo to Molluscum. 0 None 0 150 143 150 View
Placebo Vehicle Film Forming Solution applied via a prefilled applicator to affected area every 21 days Placebo: Placebo to be applied via the applicator to Molluscum lesions Applicator: Used to apply the topical film forming Active or Placebo to Molluscum. 0 None 0 112 74 112 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Application site vesicles SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (20.0) View
Application site scab SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (20.0) View
Application site pruritus SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (20.0) View
Application site erythema SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (20.0) View
Application site dryness SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (20.0) View
Application site discolouration SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (20.0) View
Application site erosion SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA (20.0) View
Application site Pain SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (20.0) View
Application site oedema SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (20.0) View